Canadá - inglês - Health Canada

aa pharma inc - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics

Canadá - inglês - Health Canada

mylan pharmaceuticals ulc - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics

Canadá - inglês - Health Canada

auro pharma inc - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics

Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - clozapine 25 mg - tablet - 25 mg - clozapine 25 mg - clozapine

Israel - inglês - Ministry of Health

taro international ltd, israel - clozapine - tablets - clozapine 25 mg - clozapine - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics.reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state.suicidal behavior refers to actions by a patient that put him/herself at risk for death

Estados Unidos - inglês - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozapine tablets are indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with their use, clozapine tablets should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)]. the effectiveness of clozapine tablets in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine tablets and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)]. clozapine tablets are indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/he

Canadá - inglês - Health Canada

aa pharma inc - clozapine - tablet - 100mg - clozapine 100mg - atypical antipsychotics

Canadá - inglês - Health Canada

aa pharma inc - clozapine - tablet - 50mg - clozapine 50mg - atypical antipsychotics

Canadá - inglês - Health Canada

aa pharma inc - clozapine - tablet - 200mg - clozapine 200mg - atypical antipsychotics

Canadá - inglês - Health Canada

mylan pharmaceuticals ulc - clozapine - tablet - 100mg - clozapine 100mg - atypical antipsychotics